Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Wellnex Life Ltd ( (AU:WNX) ) just unveiled an announcement.
Wellnex Life has reported a significant operational turnaround for the first half of FY26, with EBITDA improving by $2.4 million year-on-year and group gross margin rising from 22.8% to 31.3%, enabling the business to reach breakeven by the end of the second quarter. The Pain Away brand continued to gain traction, delivering $3.3 million in quarterly sales, expanding margins by 7.6%, and outpacing category growth in heat patches and roll-ons, supported by new product launches and expanded distribution through Priceline, major pharmacy wholesalers, and upcoming Costco trials, positioning the company for more stable and sustainable performance into the second half of the year.
The most recent analyst rating on (AU:WNX) stock is a Hold with a A$0.14 price target. To see the full list of analyst forecasts on Wellnex Life Ltd stock, see the AU:WNX Stock Forecast page.
More about Wellnex Life Ltd
Wellnex Life Limited is an ASX- and AIM-listed health and wellness company focused on consumer healthcare products, including its Pain Away topical pain relief brand, with a strong presence in Australian pharmacy and retail channels and growing distribution through major chains such as Priceline and Costco in Australia and New Zealand.
Average Trading Volume: 77,938
Technical Sentiment Signal: Sell
Current Market Cap: A$10.49M
For a thorough assessment of WNX stock, go to TipRanks’ Stock Analysis page.